![]() |
市场调查报告书
商品编码
1862367
重离子治疗技术:全球市场份额和排名、总收入和需求预测(2025-2031 年)Heavy Ion Therapy Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球重离子放射治疗技术市场规模估计为 6.32 亿美元,预计到 2031 年将扩大到 23.58 亿美元,2025 年至 2031 年的复合年增长率为 19.6%。
重离子放射疗法(HIR)是一种先进的癌症治疗方法,它利用了重粒子独特的物理和生物学特性。 HIR 将碳离子和其他重离子加速到接近光速的速度。这些高能量离子被瞄准肿瘤,将聚焦的辐射剂量直接送到癌细胞。与传统的 X 光疗法沿着人体整个路径释放能量不同,重离子放射疗法具有独特的能量释放模式。辐射剂量随深度增加,并在一个特定点达到最大值,该点称为布拉格峰。布拉格峰可以被精确地定位在肿瘤内。这使得辐射能够高度靶向地输送,并最大限度地减少对周围正常组织的损伤。本报告重点介绍重离子放射疗法市场所需的设备。
传统的重离子放射治疗系统仅使用碳离子,而多离子放射治疗则结合了针对特定恶性肿瘤优化的多种离子束,从而能够以更少的副作用杀死更多癌细胞。 2022年,韩国量子科学技术振兴机构(QST)和重离子科学研究所(SHI)成功研发出使用氖离子、氧离子和氦离子的多离子源,使多离子放射治疗的实现更进一步。该系统已安装在位于千叶的QST重离子医学加速器(HIMAC)上,用于进一步研究。利用该系统,比碳重的氧离子照射到肿瘤中心,而比碳轻的氦离子则照射到靠近正常组织的区域。研究人员还分析了剂量分布和生物效应分布。与碳离子单药治疗的比较证实,不同离子束的合併治疗更为有效。肉瘤的手术治疗常会导致神经损伤(神经病变),具体情况取决于手术部位。重离子放射治疗即使在治疗难治性患者方面也取得了良好的效果。此外,治疗体积较大的肿瘤时,復发是常见问题。首例采用多离子疗法的病例于2023年11月至12月进行,对同一患者共进行了16次治疗。这是首次在同一天进行碳离子和氧离子疗法,两种疗法之间的切换也进行得非常顺利。患者在治疗后第二天出院,并在两个月后的后续观察中未观察到早期副作用。
本报告旨在按地区/国家、类型和应用对全球重离子治疗技术市场进行全面分析,重点关注总收入、市场份额和主要企业的排名。
本报告以收益为准,以2024年为基准年,对重离子治疗技术的市场规模、估算和预测进行了阐述,并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析旨在帮助读者制定业务/成长策略、评估市场竞争、分析公司在当前市场中的地位,并就重离子治疗技术做出明智的商业决策。
市场区隔
公司
按类型分類的细分市场
应用领域
按地区
The global market for Heavy Ion Therapy Technology was estimated to be worth US$ 632 million in 2024 and is forecast to a readjusted size of US$ 2358 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Heavy Ion Therapy Technology, or Heavy ion radiotherapy (HIR) is a sophisticated form of cancer treatment that employs accelerated heavy ions, most commonly carbon, to precisely target and destroy tumors. This method distinguishes itself from traditional radiotherapy by leveraging the unique physical and biological properties of these heavy ions. In HIR, carbon or other heavy ions are accelerated to a substantial fraction of the speed of light. These high-energy ions are then directed towards the tumor, delivering a concentrated dose of radiation directly to the cancerous cells. Unlike conventional X-ray therapy, which deposits energy along its entire path through the body, heavy ion therapy exhibits a distinct energy deposition pattern. The radiation dose increases with depth, reaching a maximum at a specific point known as the Bragg peak, which can be precisely positioned within the tumor. This allows for a highly targeted delivery of radiation, minimizing damage to surrounding healthy tissues. This report focuses on the devices for heavy ion therapy technology market.
In conventional heavy-particle radiotherapy equipment, only carbon ions are used. In multi-ion therapy, on the other hand, various kinds of ion beams-optimal for the specific malignancy-are combined to kill more cancer cells with fewer side effects. In 2022, QST and SHI succeeded in creating a multi-ion source, using neon, oxygen, and helium ions among others, making multi-ion radiotherapy possible. The system was installed at QST's Heavy Ion Medical Accelerator in Chiba (HIMAC) for further research. With the new system, oxygen, heavier than carbon, was irradiated to the center of a tumor, and helium, lighter than carbon, was irradiated to an area nearer to normal tissue. Dose distribution and distribution of biological effects were also analyzed. Through a comparison with cases where only carbon ions were irradiated, it was confirmed that using different ion beams was more effective. In surgical treatments for sarcoma, depending on the site of the operation, patients often experience nerve injuries (neuropathy). Satisfactory results have been obtained using heavy ions, even for those patients for whom surgery would not have been possible. Moreover, in treatments of very large tumors, recurrence has been a frequent problem. The first case using multi-ion therapy occurred in November and December 2023, involving irradiation applied on the same patient 16 times. For the first time, carbon and oxygen irradiations were done on the same day, and switching between them was conducted smoothly. The patient was discharged the day after the treatments ended, and no early side effects were seen two months later.
This report aims to provide a comprehensive presentation of the global market for Heavy Ion Therapy Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Heavy Ion Therapy Technology by region & country, by Type, and by Application.
The Heavy Ion Therapy Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heavy Ion Therapy Technology.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heavy Ion Therapy Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Heavy Ion Therapy Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Heavy Ion Therapy Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.